Skip to main content
. 2020 Dec 17;25(24):5979. doi: 10.3390/molecules25245979

Figure 2.

Figure 2

The effect of rHct-S3 on cell viability of (a) normal mouse epidermal cells JB6 Cl41, human (b) embryonic kidney HEK 293, (c) colorectal carcinoma HT-29, (d) breast cancer MDA-MB-231, and (e) melanoma SK-MEL-28 cell lines. The cytotoxic activity was determined by MTS assay after 24 h of treatment. The results are expressed as the percentage of inhibition that produced a reduction in absorbance by rHct-S3 treatment compared the non-treated cells. Results are expressed as the mean ± standard deviation (SD).